DE69942314D1 - Versuchsanordnung zum nachweis von bindungspartnern - Google Patents

Versuchsanordnung zum nachweis von bindungspartnern

Info

Publication number
DE69942314D1
DE69942314D1 DE69942314T DE69942314T DE69942314D1 DE 69942314 D1 DE69942314 D1 DE 69942314D1 DE 69942314 T DE69942314 T DE 69942314T DE 69942314 T DE69942314 T DE 69942314T DE 69942314 D1 DE69942314 D1 DE 69942314D1
Authority
DE
Germany
Prior art keywords
binding partners
detecting binding
trial assembly
leukemia
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69942314T
Other languages
English (en)
Inventor
Richard Ian Christopherson
Remedios Cristobal G Dos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medsaic Pty Ltd
Original Assignee
Medsaic Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP7916A external-priority patent/AUPP791698A0/en
Priority claimed from AUPQ0425A external-priority patent/AUPQ042599A0/en
Application filed by Medsaic Pty Ltd filed Critical Medsaic Pty Ltd
Application granted granted Critical
Publication of DE69942314D1 publication Critical patent/DE69942314D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Basic Packing Technique (AREA)
  • Motorcycle And Bicycle Frame (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69942314T 1998-12-23 1999-12-23 Versuchsanordnung zum nachweis von bindungspartnern Expired - Lifetime DE69942314D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP7916A AUPP791698A0 (en) 1998-12-23 1998-12-23 An assay
AUPQ0425A AUPQ042599A0 (en) 1999-05-18 1999-05-18 An assay-ii
PCT/AU1999/001156 WO2000039580A1 (en) 1998-12-23 1999-12-23 An assay to detect a binding partner

Publications (1)

Publication Number Publication Date
DE69942314D1 true DE69942314D1 (de) 2010-06-10

Family

ID=25645962

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69942314T Expired - Lifetime DE69942314D1 (de) 1998-12-23 1999-12-23 Versuchsanordnung zum nachweis von bindungspartnern

Country Status (15)

Country Link
US (1) US7560226B2 (de)
EP (1) EP1151300B1 (de)
JP (1) JP4763135B2 (de)
KR (1) KR100795757B1 (de)
CN (1) CN1231761C (de)
AT (1) ATE466280T1 (de)
BR (1) BR9916449A (de)
CA (1) CA2356286C (de)
DE (1) DE69942314D1 (de)
DK (1) DK1151300T3 (de)
ES (1) ES2344180T3 (de)
HK (1) HK1041922A1 (de)
NZ (1) NZ525421A (de)
PT (1) PT1151300E (de)
WO (1) WO2000039580A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1051624A4 (de) * 1998-01-29 2002-05-02 Glaucus Proteomics B V Hochdichte matrizen zur proteomanalyse und verfahren und zusammensetzungen dafür
AUPR005600A0 (en) * 2000-09-12 2000-10-05 University Of Sydney, The Diagnostic assay
AU2002231028B2 (en) 2000-12-14 2008-01-31 Paul Stroobant Differential phage capture proteomics
EP1248108B1 (de) * 2001-03-29 2011-08-31 Canon Kabushiki Kaisha Verfahren zum Zellscreening und dafür geeignete Substrata
CA2443777A1 (en) * 2001-04-10 2002-10-24 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic and diagnostic uses of antibody specificity profiles
US20030044389A1 (en) * 2001-07-02 2003-03-06 Brown Patrick O. Microarrays for cell phenotyping and manipulation
ATE443259T1 (de) 2001-09-20 2009-10-15 Univ Texas Bestimmung der zirkulierenden therapeutischen antikörper, antigene sowie antigen-antikörper- komplexe mit elisa-tests
EP2299274A1 (de) 2002-03-07 2011-03-23 Medical Research Council SCD Fingerabdrücke
CA2490522A1 (en) * 2002-06-20 2003-12-31 Paul Stroobant Improved methods for performing differential capture proteomics
DE10236101A1 (de) * 2002-08-05 2004-02-26 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Verfahren und Kit zur Durchführung funktioneller Tests an biologischen Zellen
WO2004106925A2 (en) * 2003-03-03 2004-12-09 Nagaoka & Co.Ltd. Methods and apparatus for use in detection and quantitation of various cell types and use of optical bio-disc for performing same
WO2004087865A2 (en) * 2003-03-31 2004-10-14 The Regents Of The University Of California The preparation and application of ligand-biopolymer conjugates
SE0301058D0 (sv) 2003-04-10 2003-04-10 Biacore Ab Method and kit for cell analyte assay
EP1611443A1 (de) * 2003-04-04 2006-01-04 Biacore AB Verfahren und kit für einen zellanalyt-assay
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US20080138808A1 (en) * 2003-09-11 2008-06-12 Hall Thomas A Methods for identification of sepsis-causing bacteria
US8288523B2 (en) 2003-09-11 2012-10-16 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US8546082B2 (en) * 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US20050069958A1 (en) * 2003-09-26 2005-03-31 Mills Rhonda A. Method for simultaneous evaluation of a sample containing a cellular target and a soluble analyte
DE102004039628A1 (de) * 2004-08-10 2006-02-23 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Trägerplatte zur Durchführung funktioneller Tests an biologischen Zellen sowie Verfahren zur Beschichtung der Trägerplatte
EP1888784A2 (de) * 2005-05-18 2008-02-20 Wyeth a Corporation of the State of Delaware Leukämiekrankheitsgene und verwendungen davon
US20060275852A1 (en) * 2005-06-06 2006-12-07 Montagu Jean I Assays based on liquid flow over arrays
US20070042443A1 (en) 2005-08-17 2007-02-22 Quest Diagnostics Investments Incorporated Hematopoietic cell phenotyping using free circulating cellular markers
US7955837B2 (en) * 2005-10-29 2011-06-07 Bayer Technology Services Gmbh Process for determining one or more analytes in samples of biological origin having complex composition, and use thereof
US20070105165A1 (en) * 2005-11-04 2007-05-10 Charles Goolsby Composite profiles of cell antigens and target signal transduction proteins for analysis and clinical management of hematologic cancers
JP5102772B2 (ja) 2005-11-29 2012-12-19 ザ・ユニバーシティ・オブ・シドニー デミボディ：二量体化活性化治療剤
US20070192884A1 (en) * 2006-01-25 2007-08-16 Daniel Chelsky TAT-038 and methods of assessing and treating cancer
US8768629B2 (en) * 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
CN103424541B (zh) 2006-05-18 2018-01-30 分子压型学会股份有限公司 确定针对病状的个性化医疗介入的系统和方法
US20110003710A1 (en) * 2008-02-28 2011-01-06 John Hopkins University Selectin ligands useful in the diagnosis and treatment of cancer
GB0818614D0 (en) * 2008-10-10 2008-11-19 Univ Dublin City Platelet Analysis
EP3075864A1 (de) * 2008-10-14 2016-10-05 Caris MPI, Inc. Gen und genexprimierte zielproteine zur darstellung von biomarkermustern und signatursets nach tumortyp
CN102301002A (zh) * 2008-11-12 2011-12-28 卡里斯生命科学卢森堡控股有限责任公司 使用外来体来确定表现型的方法和系统
JP5808349B2 (ja) 2010-03-01 2015-11-10 カリス ライフ サイエンシズ スウィッツァーランド ホールディングスゲーエムベーハー セラノーシスのためのバイオマーカー
JP2013526852A (ja) 2010-04-06 2013-06-27 カリス ライフ サイエンシズ ルクセンブルク ホールディングス 疾患に対する循環バイオマーカー
WO2012048372A1 (en) * 2010-10-11 2012-04-19 Medsaic Pty Ltd Assay for disease detection
ES2578160T3 (es) 2011-08-12 2016-07-21 Lsi Medience Corporation Procedimiento de diagnóstico de infecciones de sitio quirúrgico
CN103235124A (zh) * 2013-04-22 2013-08-07 复旦大学 一种基于硝酸纤维素膜的便捷癌细胞捕获芯片
EP3011061B1 (de) * 2013-06-21 2021-12-29 The Johns Hopkins University Virionenanzeigearray zum profilieren von funktionen und wechselwirkungen menschlicher membranproteine
US20180031575A1 (en) * 2014-11-20 2018-02-01 Ge Healthcare Uk Limited Detecting Dementia and Alzheimer's Disease Associated Biomarkers Stabilized on Solid Support Materials
CN105005484B (zh) * 2015-08-12 2021-04-20 厦门雅基软件有限公司 一种跨平台游戏开发工具的事件分发方法
AU2018301222A1 (en) * 2017-07-08 2020-01-30 The General Hospital Corporation Screening platform to identify therapeutic drugs or agents for treatment of alzheimer's disease

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS589070A (ja) * 1981-04-29 1983-01-19 チバ−ガイギ−・アクチエンゲゼルシヤフト 免疫分析用装置及びキツト
US4591570A (en) * 1983-02-02 1986-05-27 Centocor, Inc. Matrix of antibody-coated spots for determination of antigens
US4797356A (en) * 1985-12-02 1989-01-10 Konishiroku Photo Industries, Co., Ltd Monoclonal antibodies specific to glactosyltransferase isoenzyme II and their use in cancer immunoassays
US5426029A (en) * 1986-03-31 1995-06-20 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using leukocyte surface antigens
US5217869A (en) * 1987-10-13 1993-06-08 Terrapin Technologies, Inc. Method to produce immunodiagnostic reagents
GB8810400D0 (en) * 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5059522A (en) * 1988-08-18 1991-10-22 Wayne Lawrence G Intrinsic enzyme dot blot immunoassay or indentification of microorganisms
US6040138A (en) * 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5532135A (en) * 1990-02-02 1996-07-02 Cancer Research Fund Of Contra Costa Solid-phase competitive assay utilizing a fusion protein
US5726064A (en) * 1990-11-22 1998-03-10 Applied Research Systems Ars Holding Nv Method of assay having calibration within the assay
US5234816A (en) * 1991-07-12 1993-08-10 Becton, Dickinson And Company Method for the classification and monitoring of leukemias
US5597735A (en) * 1992-05-11 1997-01-28 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Health And Welfare Glycolipids for serodiagnosis of tuberculosis and leprosy
AU5010793A (en) * 1992-08-21 1994-03-15 Schering Corporation Human interleukin-13
ES2051651B1 (es) * 1992-12-10 1995-01-01 Univ Salamanca Procedimiento para la cuantificacion simultanea, en una sola medicion, de los principales tipos de linfocitos humanos y sus subpoblaciones.
EP0610774B1 (de) * 1993-02-09 2001-03-28 Becton, Dickinson and Company Automatische Bestimmung der Zellinie schwerer Leukämien durch Flusszytometrie
AU7556994A (en) * 1993-08-13 1995-03-14 Molecular Geriatrics Corporation Methods for the diagnosis of alzheimer's disease
US5692220A (en) * 1993-09-02 1997-11-25 Coulter Corporation Decision support system and method for diagnosis consultation in laboratory hematopathology
DE69433967D1 (de) * 1993-10-06 2004-09-30 Univ Florida Stammzellen-proliferations-faktor
US5861158A (en) * 1993-11-17 1999-01-19 The United States Of America As Represented By The Deptartment Of Health And Human Services Method and composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor
JP3533541B2 (ja) * 1995-01-25 2004-05-31 旭メディカル株式会社 細胞選択フィルター
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
US6265150B1 (en) * 1995-06-07 2001-07-24 Becton Dickinson & Company Phage antibodies
US5968513A (en) 1996-06-24 1999-10-19 University Of Maryland Biotechnology Institute Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin
AU4327697A (en) * 1996-08-20 1998-03-06 Motorola, Inc. Method and apparatus for detecting predetermined molecular structures in a sample
US6087102A (en) 1998-01-07 2000-07-11 Clontech Laboratories, Inc. Polymeric arrays and methods for their use in binding assays
JP2002502977A (ja) 1998-02-04 2002-01-29 インビトロジェン コーポレイション マイクロアレイとその使用

Also Published As

Publication number Publication date
JP2002533723A (ja) 2002-10-08
EP1151300A1 (de) 2001-11-07
WO2000039580A1 (en) 2000-07-06
US7560226B2 (en) 2009-07-14
KR100795757B1 (ko) 2008-01-21
KR20010093221A (ko) 2001-10-27
CN1231761C (zh) 2005-12-14
CA2356286A1 (en) 2000-07-06
EP1151300B1 (de) 2010-04-28
ATE466280T1 (de) 2010-05-15
ES2344180T3 (es) 2010-08-19
BR9916449A (pt) 2002-01-22
HK1041922A1 (en) 2002-07-26
CA2356286C (en) 2010-12-21
JP4763135B2 (ja) 2011-08-31
CN1334922A (zh) 2002-02-06
EP1151300A4 (de) 2002-07-31
US20020019018A1 (en) 2002-02-14
PT1151300E (pt) 2010-06-21
NZ525421A (en) 2004-10-29
DK1151300T3 (da) 2010-07-12

Similar Documents

Publication Publication Date Title
DE69942314D1 (de) Versuchsanordnung zum nachweis von bindungspartnern
TR200000565T2 (tr) Biyolojik örneklerdeki analiz bileşenlerinin hızlı analizi için yöntem
ATE254285T1 (de) Geräte und verfahren, die strukturfelder zum binden von analyten verwenden
ATE290205T1 (de) Vorrichtung und verfahren zum nachweis und identifizieren von infektiösen wirkstoffen
EP0797777A4 (de) Vorrichtung zur durchführung eines oder mehrerer kompetitiver ummunoassays
ES2187622T3 (es) Reactivos y dispositivos de ensayo.
DE69623458T2 (de) Einstufige immunochromatographische vorrichtung und verfahren zu ihrer verwendung
DE68904370D1 (de) Vorrichtung fuer biologische analysen mittels enzymimmun-test von antikoerpern oder antigenen in einem serum.
ATE461450T1 (de) Verwendung von kontrollflächen zur detektion von störproben in einem nachweisverfahren
TR200001313T2 (tr) Protein etkileşimlerini ve fonksiyonel ilişkileri kaydeden tarama sistemleri
DE69928507D1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
NO20083610L (no) Cobalamin-maling
ATE285581T1 (de) Assay-verfahren
DE68919387D1 (de) DNS- und RNS-Proben, Methoden und Testsätze zum Nachweis von Salmonella.
DE69617568T2 (de) Immunoassay Vorrichtung und Testverfahren zu seiner Verwendung
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
ATE215095T1 (de) Immunologisches testverfahren zur quantifizierung von peg-modifiziertem humanem granulozyten- kolonie-stimulierender-faktor
DE69313664T2 (de) Immonoassay
ATE312203T1 (de) Dynamische bestimmung von analyten durch arrays auf inneren oberflächen
SE9303272D0 (sv) Improvement in immunoassays
DK0998974T3 (da) Fremgangsmåde til målrettet anbringelse af reagenser på immobiliseret biologisk materiale

Legal Events

Date Code Title Description
8364 No opposition during term of opposition